SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹8.91 Cr | ₹6.03 Cr | ₹5.62 Cr | ₹4.59 Cr | ₹4.44 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUDEEP PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹8.91 Cr |
| Mar2025 | ₹6.03 Cr |
| Mar2024 | ₹5.62 Cr |
| Mar2023 | ₹4.59 Cr |
| Mar2022 | ₹4.44 Cr |
How is Deferred Tax Assets / Liabilities of SUDEEP PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.91 Cr | 47.63 | |
| Mar2025 | ₹6.03 Cr | 7.40 | |
| Mar2024 | ₹5.62 Cr | 22.42 | |
| Mar2023 | ₹4.59 Cr | 3.26 | |
| Mar2022 | ₹4.44 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹12,503.7 Cr | 5.1% | 25.4% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 5.1% |
25.4% |
|
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses